News Center
Current page: Home > News ContentNews Content
The year of 2015 can be regarded as the historical turning point for the rapid development of Minxiang Biomedical. Thanks for ten years of endeavors, Minxiang Biomedical hardened its foundation in capricious market and started to conduct leap-type marketing based on the constant trace to group’s advantages on major businesses. Ten years’ accumulation makes it possible for Minxiang Biomedical to continuously maintain great progresses in the process of chasing after dreams in spite of endless difficulties, moving forward bravely with happiness and hopes.
From June 24th to 26th, 2015, the 15thCPHI China is opened in Shanghai New International Expo Center of Pudong New Area, attracting forty-five thousand professional buyers from more than one hundred forty countries and regions. As a large-scale special platform for trades and exhibitions of international advanced pharmaceutical products; ,the powerful brand charisma of CPHI China has developed into a significant channel for Chinese pharmaceutical industry to step into international markets.
As the largest manufacturer for series products of amantadine hydrochloride all around the world, Minxiang Biomedical attended the CPHI China for the eighth time. Guided by Chairman, Liu Wanli, the delegation of Minxiang Biomedical had made an appointment with important overseas and domestic customers in advance and determined the time for negotiations; communicated with them effectively, comprehensively and frankly; and won their high-level reliance because of our long-term and stable supply of superior quality products and sustainable development as a distributor (our company has passed authentication of ISO9001, ISO14001, and OHSAS18001).
One of the achievements during the exhibition was that we had concluded an annual framework agreement from 2015 to 2016 on supply chains with important overseas and domestic customers and confirmed the further cooperative intentions in the fields of new products research and development, contract customization, and market coordination. In the meantime, newly-released products, 1-Adamantanol and 2-Adamantanone, were popularized vigorously at the exhibition.
Relying on this large-scale special platform, Minxiang Biomedical continuously improved the ability of attending and arranging an exhibition; effectively promoted the overall image of Carelean Group; and unceasingly shortened the gap with these famous enterprises at home and abroad in the same industry. What’s more, we grasped the trend and rules of market development, contacted with many new customers and advanced products, established new cooperation, broaden the company’s business scope and obtained some achievements in the field of electronic products, except for the fields of raw materials for medicine and environment-friendly products.
This exhibition laid a sound foundation for our company’s further expansion of the domestic and foreign markets and the creative and leap-type development in the following days.
